Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bryan Brewer

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
The American Journal of Cardiology|September 2, 2003
Benefit-risk assessment of Rosuvastatin 10 to 40 milligramsH Bryan Brewer
American Heart Journal|June 24, 2004
A new dawn in the treatment of dyslipidemia: cardiovascular risk reduction through emerging science and proven clinical results. IntroductionH Bryan Brewer
The Journal of Clinical Endocrinology and Metabolism|March 11, 2011
Clinical review: The evolving role of HDL in the treatment of high-risk patients with cardiovascular diseaseH Bryan Brewer
The New England Journal of Medicine|April 9, 2004
Increasing HDL Cholesterol LevelsH Bryan Brewer
The American Journal of Managed Care|February 22, 2002
Rising to the challenge of the new NCEP ATP III guidelines: exceeding current therapeutic limitationsH Bryan Brewer
American Heart Journal|June 24, 2004
Focus on high-density lipoproteins in reducing cardiovascular riskH Bryan Brewer
Arteriosclerosis, Thrombosis, and Vascular Biology|March 9, 2004
High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular diseaseH Bryan Brewer
Clinical Cardiology|April 24, 2003
New features of the National Cholesterol Education Program Adult Treatment Panel III lipid-lowering guidelinesH Bryan Brewer
Current Cardiology Reports|November 15, 2007
HDL metabolism and the role of HDL in the treatment of high-risk patients with cardiovascular diseaseH Bryan Brewer
The American Journal of Cardiology|April 8, 2003
New insights into the role of the adenosine triphosphate-binding cassette transporters in high-density lipoprotein metabolism and reverse cholesterol transportH Bryan Brewer, Silvia Santamarina-Fojo
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
The American Journal of Cardiology|September 2, 2003
Benefit-risk assessment of Rosuvastatin 10 to 40 milligramsH Bryan Brewer
American Heart Journal|June 24, 2004
A new dawn in the treatment of dyslipidemia: cardiovascular risk reduction through emerging science and proven clinical results. IntroductionH Bryan Brewer
The Journal of Clinical Endocrinology and Metabolism|March 11, 2011
Clinical review: The evolving role of HDL in the treatment of high-risk patients with cardiovascular diseaseH Bryan Brewer
The New England Journal of Medicine|April 9, 2004
Increasing HDL Cholesterol LevelsH Bryan Brewer
The American Journal of Managed Care|February 22, 2002
Rising to the challenge of the new NCEP ATP III guidelines: exceeding current therapeutic limitationsH Bryan Brewer
American Heart Journal|June 24, 2004
Focus on high-density lipoproteins in reducing cardiovascular riskH Bryan Brewer
Arteriosclerosis, Thrombosis, and Vascular Biology|March 9, 2004
High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular diseaseH Bryan Brewer
Clinical Cardiology|April 24, 2003
New features of the National Cholesterol Education Program Adult Treatment Panel III lipid-lowering guidelinesH Bryan Brewer
Current Cardiology Reports|November 15, 2007
HDL metabolism and the role of HDL in the treatment of high-risk patients with cardiovascular diseaseH Bryan Brewer
The American Journal of Cardiology|April 8, 2003
New insights into the role of the adenosine triphosphate-binding cassette transporters in high-density lipoprotein metabolism and reverse cholesterol transportH Bryan Brewer, Silvia Santamarina-Fojo
Pageof 8